{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:51:43Z","timestamp":1756385503334},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,1,6]],"date-time":"2006-01-06T00:00:00Z","timestamp":1136505600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s00277-005-0052-6","type":"journal-article","created":{"date-parts":[[2006,1,5]],"date-time":"2006-01-05T17:23:32Z","timestamp":1136481812000},"page":"188-190","source":"Crossref","is-referenced-by-count":6,"title":["Successful treatment of lymph node extramedullary plasmacytoma with bortezomib"],"prefix":"10.1007","volume":"85","author":[{"given":"D.","family":"Pantelidou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Tsatalas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Margaritis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. G.","family":"Anastasiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Kaloutsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Argyropoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Prassopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bourikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,1,6]]},"reference":[{"key":"52_CR1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0167-8140(90)90003-F","volume":"17","author":"NA Mayr","year":"1990","unstructured":"Mayr NA, Wen BC, Hussey DH (1990) The role of radiation therapy in the treatment of solitary plasmacytomas. Radiother Oncol 17:293","journal-title":"Radiother Oncol"},{"issue":"6","key":"52_CR2","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0889-8588(05)70124-6","volume":"13","author":"MA Dimopoulos","year":"1999","unstructured":"Dimopoulos MA, Kiamouris C, Moulopoulos LA (1999) Solitary plasmacytoma of bone and extramedullary plasmacytoma. Hematol Oncol Clin North Am 13(6):1249\u20131257","journal-title":"Hematol Oncol Clin North Am"},{"key":"52_CR3","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.leukres.2005.05.003","volume":"29","author":"M-T Krauth","year":"2005","unstructured":"Krauth M-T, Bankier A, Valent P, Kalhs P, Drach J (2005) Sustained remission including marked regression of a paravertebral plasmacytoma in a patient with heavily pretreated, relapsed multiple myeloma after treatment with bortezomib. Leuk Res 29:1473\u20131477","journal-title":"Leuk Res"},{"key":"52_CR4","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/sj.leu.2403855","volume":"19","author":"E Paubelle","year":"2005","unstructured":"Paubelle E, Coppo P, Garderet L, Azizi L, Bories D, Gorin NC, Fouillard L (2005) Complete remission with bortezomib on plasmacytomas in an end-stage patient with refractory multiple myeloma who failed all other therapies including hematopoietic stem cell transplantation: possible enhancement of graft-vs-tumor effect. Leukemia 19:1702\u20131704","journal-title":"Leukemia"},{"issue":"3","key":"52_CR5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00277-004-0854-y","volume":"84","author":"D Pantelidou","year":"2005","unstructured":"Pantelidou D, Tsatalas C, Margaritis D, Karayannakis AJ, Kaloutsi V, Spanoudakis E, Katsilieris I, Chatzipaschalis E, Sivridis E, Bourikas G (2005) Ann Hematol 84(3):188\u2013191","journal-title":"Ann Hematol"},{"key":"52_CR6","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2305::AID-CNCR2>3.0.CO;2-3","volume":"85","author":"C Alexiou","year":"1998","unstructured":"Alexiou C, Kau R, Dietzfelbinger H, Kremer M, Spieb J, Schratzenstaller B, Amold W (1998) Extramedullary plasmacytoma. Tumour occurrence and therapeutic concepts. Cancer 85:2305\u20132314","journal-title":"Cancer"},{"issue":"12","key":"52_CR7","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.bmt.1703292","volume":"28","author":"JJ Biagi","year":"2001","unstructured":"Biagi JJ, Mileskin L, Grigg AP, Westerman DW, Prince HM (2001) Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation. Bone Marrow Transplant 28(12):1145\u20131150","journal-title":"Bone Marrow Transplant"},{"key":"52_CR8","first-page":"234","volume":"135","author":"B Mayers","year":"2000","unstructured":"Mayers B, Grimley C, Crouch D, Dolan G (2000) Lack of response to thalidomide in plasmacytomas. Br J Haematol 135:234","journal-title":"Br J Haematol"},{"key":"52_CR9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3109\/10428190109099330","volume":"42","author":"A Avigdor","year":"2001","unstructured":"Avigdor A, Raanani P, Levi I, Hardan I, Ben-Bassat I (2001) Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide in multiple myeloma. Leuk Lymphoma 42:683\u2013687","journal-title":"Leuk Lymphoma"},{"key":"52_CR10","first-page":"832","volume":"89","author":"L Rosinol","year":"2004","unstructured":"Rosinol L, Cibeira MT, Blade J, Esteve J, Aymerich M, Rozman M, Segarra M, Cid MC, Filella X, Montserrat E (2004) Extramedullary multiple myeloma escapes the effect of thalidomide. Haematologica 89:832\u2013836","journal-title":"Haematologica"},{"key":"52_CR11","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","volume":"351","author":"RA Kyle","year":"2004","unstructured":"Kyle RA, Rajkumar SV (2004) Multiple myeloma. N Engl J Med 351:1860\u20131873","journal-title":"N Engl J Med"},{"key":"52_CR12","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa030288","volume":"348","author":"PG Richardson","year":"2003","unstructured":"Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, Rajkumar SV, Srkalovic G, Alsina M, Alexanian R, Siegel D, Orlowski RZ, Kuter D, Limentani SA, Lee S, Hideshima T, Esseltine D-L, Kauffman M, Adams J, Schenkein DP, Anderson KC (2003) A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 348:2609\u20132617","journal-title":"N Engl J Med"},{"key":"52_CR13","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa043445","volume":"352","author":"PG Richardson","year":"2005","unstructured":"Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Coldschmidt H, Reece D, San-Miguel JF, Blade J, Boccadoro M, Cavenagh J, Dalton WS, Boral AL, Esseltine DL, Porter JB, Schenkein D, Anderson KC, for the assessment of proteasome inhibition for extending remissions (APEX) investigators (2005) Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 352:2487\u20132498","journal-title":"N Engl J Med"},{"issue":"2","key":"52_CR14","first-page":"278","volume":"90","author":"F Patriarcca","year":"2005","unstructured":"Patriarcca F, Prosdocimo S, Tomadini V, Vasciaveo A, Bruno B, Fanin R (2005) Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogenic transplantation. Haematologica 90(2):278\u2013279","journal-title":"Haematologica"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-0052-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-005-0052-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-0052-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:44:49Z","timestamp":1559036689000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-005-0052-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,6]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1007\/s00277-005-0052-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,6]]}}}